Unlock powerful metabolic support with Tirzepatide, a cutting-edge dual GIP and GLP-1 receptor agonist designed to regulate blood sugar, enhance insulin sensitivity, and promote weight management. Originally developed for type 2 diabetes, Tirzepatide has gained attention for its transformative effects on body composition and appetite control.
Tirzepatide mimics two key incretin hormones—GIP and GLP-1—to:
Stimulate insulin secretion in response to meals
Suppress glucagon release
Slow gastric emptying
Reduce appetite and food intake
Blood Sugar Control: Supports healthy glucose regulation and insulin sensitivity
Weight Management: Promotes fat loss and appetite suppression
Cardiometabolic Health: May improve lipid profiles and reduce inflammation
Clinical Versatility: Suitable for research into obesity, metabolic syndrome, and type 2 diabetes
⚠️ Usage Note:
This product is intended for research purposes